GlassScriptPhysician profile
Kenneth A Bailey
NPI 1326175597
$1,336.35
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $246 · 2021: $303 · 2022: $335 · 2023: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $589.51 | 2019-2023 | Collagenase Santyl, Regranex, Grafix Pl |
| Organogenesis INC. | $126.19 | 2020-2021 | |
| Tactile Systems Technology INC | $111.53 | 2019-2022 | |
| Medtronic, INC. | $70.48 | 2021-2022 | |
| Stryker Corporation | $67.01 | 2022-2023 | Citrefix, Augment Injectable, Fixos |
| Nevro Corp. | $57.20 | 2023 | Senza |
| Medtronic Vascular, INC. | $51.28 | 2019 | |
| Grt US Holding, INC. | $50.46 | 2021-2022 | |
| Bioventus LLC | $47.30 | 2022 | |
| Acell, INC. | $38.06 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $34.35 | 2022-2023 | Nuzyra |
| Ovik Health, LLC | $27.72 | 2023 | |
| Averitas Pharma INC. | $22.19 | 2023 | Qutenza |
| Kci USA, INC. | $17.07 | 2021 | |
| Integra Lifesciences Corporation | $13.82 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $12.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.